TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Ridgeview Diagnostics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
-22
|
-44 | |
| EBITDA |
-2
|
-1 | |
| Total assets |
52
|
74 | |
| Current assets |
36
|
41 | |
| Current liabilities |
0
|
0 | |
| Equity capital |
52
|
73 | |
| - share capital |
17
|
17 | |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
100%
|
98.6% | |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-42.3%
|
-59.5% | |
| Current ratio | |||
| Return on equity (ROE) |
-42.3%
|
-60.3% | |
| Change turnover |
0
|
-13 | |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.